Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OZ439 and PQP in Induced Blood Stage Malaria
NCT03542149Phase 1Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- Apr 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of artefenomel and piperaquine in malaria, sponsored by Medicines for Malaria Venture. Started Apr 2018; status: completed.
02
Drugs
artefenomelpiperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT03542149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03542149.